IQ EQ Fund Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $489K | Hold |
995
| – | – | 0.04% | 247 |
|
|
2025
Q4 | $577K | Sell |
995
-115
| -10% | -$65K | 0.04% | 245 |
|
|
2025
Q3 | $538K | Sell |
1,110
-1,630
| -59% | -$759K | 0.04% | 256 |
|
|
2025
Q2 | $1.11M | Buy |
2,740
+28
| +1% | +$11.7K | 0.1% | 199 |
|
|
2025
Q1 | $1.35M | Sell |
2,712
-30
| -1% | -$16.2K | 0.16% | 152 |
|
|
2024
Q4 | $1.43M | Sell |
2,742
-467
| -15% | -$257K | 0.17% | 141 |
|
|
2024
Q3 | $1.98M | Buy |
3,209
+431
| +16% | +$255K | 0.21% | 137 |
|
|
2024
Q2 | $1.54M | Sell |
2,778
-85
| -3% | -$48.7K | 0.18% | 153 |
|
|
2024
Q1 | $1.66M | Sell |
2,863
-1,028
| -26% | -$577K | 0.19% | 139 |
|
|
2023
Q4 | $2.07M | Sell |
3,891
-942
| -19% | -$456K | 0.24% | 126 |
|
|
2023
Q3 | $2.45M | Sell |
4,833
-193
| -4% | -$103K | 0.5% | 72 |
|
|
2023
Q2 | $2.62M | Buy |
5,026
+134
| +3% | +$72.3K | 0.5% | 74 |
|
|
2023
Q1 | $2.82M | Sell |
4,892
-174
| -3% | -$98.1K | 0.54% | 68 |
|
|
2022
Q4 | $2.79M | Sell |
5,066
-628
| -11% | -$333K | 0.57% | 70 |
|
|
2022
Q3 | $2.89M | Sell |
5,694
-518
| -8% | -$290K | 0.65% | 56 |
|
|
2022
Q2 | $3.38M | Sell |
6,212
-406
| -6% | -$223K | 0.67% | 57 |
|
|
2022
Q1 | $3.91M | Sell |
6,618
-368
| -5% | -$211K | 0.64% | 57 |
|
|
2021
Q4 | $4.66M | Sell |
6,986
-692
| -9% | -$432K | 0.71% | 40 |
|
|
2021
Q3 | $4.39M | Hold |
7,678
| – | – | 0.67% | 46 |
|
|
2021
Q2 | $3.87M | Buy |
7,678
+681
| +10% | +$321K | 0.59% | 51 |
|
|
2021
Q1 | $3.19M | Sell |
6,997
-495
| -7% | -$236K | 0.56% | 56 |
|
|
2020
Q4 | $3.49M | Sell |
7,492
-51
| -0.7% | -$23.9K | 0.81% | 29 |
|
|
2020
Q3 | $3.33M | Sell |
7,543
-1,800
| -19% | -$744K | 1% | 27 |
|
|
2020
Q2 | $3.38M | Buy |
9,343
+92
| +1% | +$30.8K | 1.14% | 23 |
|
|
2020
Q1 | $2.62M | Buy |
9,251
+82
| +0.9% | +$25.9K | 1.07% | 25 |
|
|
2019
Q4 | $2.98M | Sell |
9,169
-520
| -5% | -$158K | 0.94% | 35 |
|
|
2019
Q3 | $2.82M | Buy |
9,689
+92
| +1% | +$26.3K | 0.91% | 34 |
|
|
2019
Q2 | $2.82M | Buy |
+9,597
| New | +$2.64M | 0.91% | 34 |
|
|
2018
Q4 | $2.24M | Hold |
10,003
| – | – | 0.82% | 42 |
|
|
2018
Q3 | $2.54M | Sell |
10,003
-1,607
| -14% | -$370K | 0.7% | 48 |
|
|
2018
Q2 | $2.4M | Buy |
+11,610
| New | +$2.46M | 0.64% | 43 |
|
|
2017
Q1 | $2.02M | Sell |
11,652
-175
| -1% | -$26.7K | 0.38% | 51 |
|
|
2016
Q4 | $1.92M | Buy |
11,827
+1,857
| +19% | +$274K | 0.35% | 54 |
|
|
2016
Q3 | $1.71M | Sell |
9,970
-418
| -4% | -$64.4K | 0.32% | 65 |
|
|
2016
Q2 | $1.67M | Buy |
10,388
+99
| +1% | +$14.6K | 0.31% | 61 |
|
|
2016
Q1 | $1.55M | Sell |
10,289
-88
| -0.8% | -$11.8K | 0.28% | 64 |
|
|
2015
Q4 | $1.64M | Sell |
10,377
-1,099
| -10% | -$147K | 0.28% | 62 |
|
|
2015
Q3 | $1.52M | Sell |
11,476
-746
| -6% | -$97.2K | 0.25% | 66 |
|
|
2015
Q2 | $1.72M | Sell |
12,222
-257
| -2% | -$33.5K | 0.25% | 62 |
|
|
2015
Q1 | $1.89M | Sell |
12,479
-2,249
| -15% | -$290K | 0.25% | 58 |
|
|
2014
Q4 | $1.84M | Buy |
+14,728
| New | +$1.79M | 0.27% | 52 |
|
Other funds holding TMO
VCM
IQ EQ Fund Management's TMO Position: Q1 2026 in Review
IQ EQ Fund Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 995 shares worth $489K. The position accounts for 0.04% of the portfolio, ranked #247.
IQ EQ Fund Management first reported a position in TMO in Q4 2014 and has held it in 41 quarters since. The position peaked at $4.66M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- IQ EQ Fund Management held 995 shares of Thermo Fisher Scientific worth $489K as of Q1 2026.
- IQ EQ Fund Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.04% of IQ EQ Fund Management's portfolio in Q1 2026, its #247 holding.
- IQ EQ Fund Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 41 quarters since.
- IQ EQ Fund Management's Thermo Fisher Scientific position peaked at $4.66M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.